Plasma Endothelin-1 Concentrations in Patients with Behçet' Disease

References

• International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–80
   PubMed Web of Science ®Google Scholar
• O'Duffy Desmond J. Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990; 16(2)423–31
   PubMed Web of Science ®Google Scholar
• Geraint JD. Behçet's disease. BJCP 1990; 44(9)364–8
   Google Scholar
• Şimşek H, Dündar S, Teletar H. Treatment of Behçet's disease with indomethacin. Int J Dermatol 1991; 30(1)54–7
   PubMed Web of Science ®Google Scholar
• Namba K, Ueno T, Okita M. Behçet's disease and streptococcal infection. Jpn J Ophthalmol 1986; 30: 385–401
   PubMed Web of Science ®Google Scholar
• Buskila D, Gladman D D, Gilmore J, Salit IE. Behçet's disease in a patient with immunodeficiency virus infection. Ann Rheum Dis 1991; 50: 115–6
   PubMed Web of Science ®Google Scholar
• Sakane T, Kotani H, Takoda S, Tsunematsu T. Functional aberration of T cells subsets in patients with Behçet's disease Arthritis Rheum. 1982; 25: 1343–51
   Google Scholar
• Suzuki N, Sakane T, Ueda Y, Tsunematsu T. Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum 1986; 29(2)212–9
   PubMed Web of Science ®Google Scholar
• Efthimiou J, Addison I E, Johnson BV. In vivo leucocyte migration in Behçet's syndrome. Ann Rheum Dis 1989; 48: 206–10
   PubMed Web of Science ®Google Scholar
• Slavin R E, Groot WJ. Pathology of the lung in Behçet's disease. Am J Surg Pathol 1981; 5: 779–88
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Uekusa T, Fukuda Y. Vasculo-Behçet's disease: A pathologoc study of eight cases. Hum Pathol 1991; 22(1)45–51
   PubMed Web of Science ®Google Scholar
• Bang D, Honma T, Saito T, Nakagawa S, Ueki H, Lee S. The pathogenesis of vascular changes in erythema nodosum-like lesions of Behçet's syndrome: An electron microscopic study. Hum Pathol 1987; 18(1)1172–9
   PubMedGoogle Scholar
• Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5
   PubMed Web of Science ®Google Scholar
• Shichiri M, Hirata Y, Ando K. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15(5)493–6
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ghatei M A, Lam H C, O'Halloran D J, Bloom SE. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306–10
   PubMed Web of Science ®Google Scholar
• Pitted J F, Morel D R, Hemsen A, Gunning K, Lacroix J S, Suter P M, et al. Elevated plasma Endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213(3)261–4
   PubMed Web of Science ®Google Scholar
• Julkuren H, Saijonmaa D, Riska C G, Teppo A M, Fyhrquist F. Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus Ann Rheum Dis. 1991; 50: 526–7
   Google Scholar
• Ishibashi M, Saito K, Watanabe K, Uesugi Furur H, Yamaji T. Plasma Endothelin-1 levels in patients with disseminated intravascular coagulation. N Engl J Med 1991; 324(21)1516–7
   PubMed Web of Science ®Google Scholar
• Kanno K, Hirata Y, Numano F, Emori T, Ohta K, Shichiri M, et al. Endothelin-1 and vasculitis. JAMA 1990; 264(22)2868
   PubMed Web of Science ®Google Scholar
• Hirata Y, Takagi Y, Fukudo Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225–8
   PubMed Web of Science ®Google Scholar
• Bobik A, Grooms A, Millar J A, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990; 258(3)C408–C15
   Google Scholar
• Neuser D, Knorr A, Stasch J P, Kazda S. Mitogenic activity of Endothelin-1 and-3 on vascular smooth muscle cells is inhibited by atrial natriuretic peptides. Artery 1990; 17(6)311–24
   PubMedGoogle Scholar
• Simonson M S, Wann S, Mene P, Dubyak G R, Kester M, Nakazato Y, et al. Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989; 83: 708–12
   PubMed Web of Science ®Google Scholar
• Saito Y, Nakao K, Itoh H. Endothelin in human plasma and culture medium of aortic endothelial cells: detection and characterization with radio immunoassay using monoclonal antibody. Bichem Biophys Res Commun 1989; 161: 320–6
   PubMed Web of Science ®Google Scholar
• Daniel T O, Gibbs V C, Milfay D F, Garovay M R, Williams LT. Thrombin stimulates c-sis gene expression in microvascular and endothelial cells. J Biol Chem 1986; 261: 9579–82
   PubMed Web of Science ®Google Scholar
• Kurihara H, Yoshizumi M, Sugiyama T. Transforming growthfactor-β stimulates the expression of endothelial mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989; 159: 1435–40
   PubMed Web of Science ®Google Scholar
• Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, et al. Increased plasma concentrations of Endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet July, 1989; 1: 53–4
   PubMedGoogle Scholar
• Sessa W C, Kaw S, Hecker M, Vane JR. The biosynthesis of Endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174(2)613–8
   PubMed Web of Science ®Google Scholar
• Sessa W C, Kaw S, Zembowicz A, Anggard E, Hecker M, Vane JR. Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases. Cardiovasc Pharmacol 1991; 17: 534–8, Suppl, 7
   Web of Science ®Google Scholar
• Maemura K, Kurihara H, Morita T, Ohhashi Y, Yazaki Y. Production of Endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992; 38: 29–35, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Patrignani P, Del-Maschio A, Bazzoni G, Daffonchio L, Hernandez A, Modica R, et al. Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes. Blood 1991; 78(10)2715–20
   PubMed Web of Science ®Google Scholar
• Fagny C, Michel A, Nortier J. Enzymatic degredation of ET-1 by activated human polymorphonuclear neutrophils. Regul Pept 1992; 42(1–2)27–37
   PubMedGoogle Scholar